Chanhen(SZ:002895)2018-05-10 16:00Dividend Distribution - The company plans to distribute a cash dividend of 1.50 RMB per 10 shares (including tax) based on the total share capital on the dividend announcement date[5]. - The company reported a cash dividend of 61,062,450 CNY for the year 2017, representing 45.77% of the net profit attributable to ordinary shareholders[85]. - The company intends to distribute a cash dividend of 1.50 CNY per 10 shares for the 2017 fiscal year, pending shareholder approval[86]. - The cash dividend policy requires a minimum of 40% of profit distribution to be in cash, reflecting the company's mature development stage[86]. - The company reported a total distributable profit of 152,156,285.87 CNY for the year 2017[86]. Financial Performance - The company's operating revenue for 2017 was ¥1,183,780,419.01, representing a year-over-year increase of 9.07% compared to ¥1,085,361,917.11 in 2016[19]. - The net profit attributable to shareholders for 2017 was ¥133,413,773.96, which is a 9.06% increase from ¥122,334,208.09 in 2016[19]. - The net profit after deducting non-recurring gains and losses decreased by 5.65% to ¥119,021,341.64 in 2017 from ¥126,151,193.06 in 2016[19]. - The net cash flow from operating activities fell by 35.76% to ¥120,550,300.20 in 2017, down from ¥187,658,077.95 in 2016[19]. - Total assets at the end of 2017 were ¥2,413,071,607.97, reflecting a 10.26% increase from ¥2,188,605,493.60 at the end of 2016[20]. - The net assets attributable to shareholders increased by 19.00% to ¥1,887,505,993.79 at the end of 2017, compared to ¥1,586,102,819.83 at the end of 2016[20]. - The company reported a basic earnings per share of ¥0.3574 for 2017, up 5.18% from ¥0.3398 in 2016[19]. Market Position and Products - The company reported a significant focus on the development of phosphate-related products, which are crucial for agricultural and industrial applications[10]. - The company emphasizes the importance of its phosphate products in various sectors, including agriculture and pharmaceuticals, highlighting its market relevance[10]. - The company maintains a leading market share in both domestic and export markets for its feed-grade phosphoric acid products[29]. - The company’s main product, feed-grade dicalcium phosphate, accounted for 67.67% of total revenue, with a revenue of CNY 801.12 million, up 5.04% year-on-year[42]. - The ammonium phosphate segment saw a significant increase in revenue by 25.84%, reaching CNY 281.69 million, which constituted 23.80% of total revenue[42]. - The company’s international sales contributed CNY 418.23 million, representing 35.33% of total revenue, with a slight increase of 0.93% year-on-year[42]. Research and Development - The total R&D expenditure was ¥35,057,203.72, which is 2.96% of the operating revenue, down from 3.32% in the previous year[54]. - The company completed the technical review of a new filling material project using semi-hydrated phosphogypsum, which is expected to significantly reduce mining costs and improve recovery rates[51]. - The company achieved a total of 4 patents in 2017, including 3 invention patents, bringing the cumulative total to 50 patents by the end of the year[52]. - The company has a total of 48 domestic authorized patents and 2 PCT patents, with over 30 additional patents under review[33]. Operational Efficiency - The company is enhancing its production capacity by upgrading its existing phosphoric acid production facilities, which will improve product quality and reduce costs[31]. - The company plans to utilize up to ¥200,000,000 of temporarily idle raised funds for cash management, primarily for purchasing safe and liquid investment products[31]. - The sales volume in the chemical industry was 427,261.91 tons, an increase of 11.32% year-on-year[46]. - The cost of phosphorite accounted for 25.13% of the total operating costs, with a total cost of ¥221,257,606.20, reflecting a 24.76% increase from the previous year[47]. Governance and Compliance - The company has engaged Xinyong Zhonghe Accounting Firm for auditing, ensuring the accuracy and reliability of its financial reports[18]. - The company has not undergone any changes in its controlling shareholders, maintaining consistent governance[17]. - The company has established a commitment to adhere to the rules regarding share transfers and reductions as stipulated by the China Securities Regulatory Commission[89]. - The company has not reported any non-standard audit reports for the reporting period[101]. - The company has established a robust governance structure with independent operation of its board, supervisory board, and management[183]. Strategic Initiatives - The company plans to focus on a circular economy and clean production, with high-performance feed phosphates and new fertilizers as the main products[75]. - The company aims for both organic growth and external expansion through capacity enhancement and strategic acquisitions[77]. - The company is committed to technological advancements, particularly in improving phosphorus absorption in animals and developing specialized fertilizers for saline-alkali land[76]. - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share within the next two years[90]. Environmental Responsibility - The company adheres to national environmental protection laws and regulations, focusing on technological innovation to minimize environmental impact[128]. - The company has implemented a 60Kt/a ammonium phosphate tail gas washing and dust removal project with a total investment of 7 million RMB, completed in January 2017[131]. - The company has constructed a 300m³/h wastewater treatment facility and a 6000m³ emergency water pool, completed in December 2017[131]. - The company is classified as a key pollutant discharge unit, with various pollutants exceeding the emission standards, including total phosphorus and SO2[130]. Employee Development - The company emphasizes employee training and development to enhance overall workforce quality and provide promotion opportunities[128]. - The company has established a training program that includes new employee orientation, skill enhancement training, and partnerships with universities for professional knowledge training[176]. - The company has a total of 451 million CNY in remuneration for directors and senior management during the reporting period[174]. - The company employs 540 production personnel, 36 sales personnel, and 126 technical personnel, indicating a strong focus on production and technical capabilities[174]. Future Outlook - The company provided a positive outlook for the next fiscal year, projecting a revenue growth of 25% driven by new product launches and market expansion strategies[90]. - Future guidance estimates a revenue growth of 12% for 2018, with a target of reaching 1.35 billion RMB[168]. - The company plans to expand its production capacity by 30% in the next fiscal year to meet rising market demand[168]. - Investment in new technology for production efficiency is projected to reduce costs by 5% over the next two years[168].